Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
In a big win for generics drugmakers, SCOTUS sides with Hikma
The U.S. Supreme Court has sided with Hikma, ruling that its generic version of Amarin’s Vascepa does not infringe patents held by the Irish company.
Kevin Dunleavy
Jun 4, 2026 3:11pm
Patient deaths raise questions about ADC's cancer drug Zynlonta
Jun 4, 2026 11:38am
How HER2 biology is shaping next-generation cancer treatment
Brought to you by
Jazz Pharmaceuticals
Axsome bars generic rivals to narcolepsy med Sunosi until 2040
Jun 4, 2026 9:35am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
